Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE907
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,103
Award facts
- Contract value 100% obligated
- $26,103.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,103.08 to AmerisourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies. This competitive, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The parent company, Cencora, Inc., operates this comprehensive global pharmaceutical support vehicle that enables the delivery of a diverse range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and other federal medical institutions worldwide. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters.
This delivery order represents one of numerous task orders executed under the broader pharmaceutical prime vendor contract structure established by DLA to support military healthcare programs globally. AmerisourceBergen's contract portfolio demonstrates the company's capability to fulfill federal procurement requirements across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, and medical supplies. The award was made on a non-set-aside, fully competitive basis, reflecting the company's ability to compete effectively among qualified pharmaceutical distributors for federal business. The contract ultimately concludes on January 8, 2026, representing the completion of this specific delivery order.
Quick answers
Who was awarded contract SPE2DU26FE907?
SPE2DU26FE907 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DU26FE907 worth?
The government has obligated $26,103 on SPE2DU26FE907.
Is contract SPE2DU26FE907 an order under another contract?
Yes. SPE2DU26FE907 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE907 competed?
The extent of competition for SPE2DU26FE907 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award